异基因造血干细胞移植治疗恶性血液病22例
摘要
异基因造血干细胞移植(allo-HSCT)可以治疗血液系统恶性疾病和一些遗传性疾病,近年来随着移植技术的改进,移植相关死亡率明显降低,allo-HSCT作为一种根治性治疗手段,越来越受到重视。
出处
《临床血液学杂志》
CAS
2010年第6期688-690,共3页
Journal of Clinical Hematology
参考文献8
-
1王峰蓉,黄晓军,任汉云,张耀臣,许兰平,陈育红,刘开彦,郭乃榄,陆道培.异基因外周血干细胞移植治疗恶性血液病[J].中华血液学杂志,2002,23(8):403-406. 被引量:18
-
2SULLIVAN K M.Graft-vs-Host Disease[M] // BL-UME K G,FORMAN S F,APPELBAUM.Thomas' Hematopoietic Cell Transplantation.3rd ed.Massachusetts:Blackwell Publishing,2004:635-664.
-
3APPELBAUM F R.Allogeneic transplantation for c-hronic myeloid leukemia[M] //BLUME K G,FORMAN S F,APPELBAUM.Thomas' Hematopoietic Cell Transplantation.3rd ed.Massachusetts:Blackwell Publishing,2004:1007-1017.
-
4GRATWOHL A,BRAND R,APPERLEY J,et al.Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006:transplant activity,long-term data and current results.An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)[J].Haematologica,2006,91:513-521.
-
5KEITH E,STOCKER G,KARL G,et al.Allogeneic Hematopoietic cell transplantation for adult patients with acute myeloid leukemia[M] //BLUME K G,FORMAN S F,APPELBAUM.Thomas' Hematopoietic Cell Transplantation.3rd ed.Massachusetts:Blackwell Publishing,2004:1025-1039.
-
6FERRANT A,LABOPIN M,FRASSONI F,et al.Karyotype in myeloblastic leukemia:prognostic significance for bone marrow transplantation in first remission:A European Group for Blood and Marrow Transplantation study.Acute leukemia Working Party of the European Group for Blood and Marrow Transplanta-tion (EBMT)[J].Blood,1997,90:2931-2938.
-
7GRIMWADE D,WALKER H,OLIVER F,et al.The importance of diagnostic cytogenetics on outcome in AML analysis of 1612 patients entered into the MRC AML 10 trials[J].Blood,1998,92:2322-2333.
-
8CUTLER C,GIRI S,JEYAPALAN S,et al.Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation:a meta-analysis[J].J Clin Oncol,2001,19:3685-3691.
二级参考文献12
-
1陆道培.骨髓移植的预处理方案[A].陆道培主编.白血病治疗学 第1版[C].北京:科学出版社,1992.327-331.
-
2Nawa Y, Teshima T, Sunami K, et al. G-CSF reduces IFN-γ and IL-4 production by T cells after allogeneic stimulation by indirectly modulating monocyte function. Bone Marrow Transplant, 2000, 25:1035-1040.
-
3Bacigalupo A, van Lint MT, Valbonesi M, et al. Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia. Blood, 1996, 88: 353-357.
-
4Trenschel R, Ross S, Husing J, et al. Reduced risk of persisting cytomegalovirus pp65 antigenemia and cytomegalovirus interstitial pneumonia following allogenenic PBSCT. Bone Marrow Transplant, 2000,25:665-672.
-
5Strob R, Deeg HJ, Farewell V, et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 1986, 68:119-125.
-
6Thomas ED, Strob R, Clift RA, et al. Bone marrow transplantation (second of the two part). N Engl J Med, 1975, 292: 895-902.
-
7Bensiger WI, Clift R, Martin P, et al. Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation. Blood, 1996, 88: 2794-2799.
-
8Champlin R, Schmitz N, Mary M, et al.Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood, 2000, 95:3702-3709.
-
9Russel JA, Brown T, Brown C, et al. Allogeneic blood cell transplants for hematological malignancy: comparison of engraftment and graft-versus-host disease with bone marrow transplantation. Bone Marrow Transplant, 1996, 17:703-708.
-
10Pan L, Delmonte J, Jalonen DK, et al. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytoking production and reduces severity of esperimental graft-versus-host-disease. Blood, 1995, 86:4422-4429.
共引文献17
-
1丁家华,陈宝安,董伟民,王骏,赵刚,高冲,孙耘玉,金宝翠,程坚.非清髓性外周血干细胞移植治疗慢性粒细胞白血病[J].白血病.淋巴瘤,2004,13(3):136-138. 被引量:1
-
2郭宏锋,李栓明,朱镭,鹿育晋,乔振华.粒细胞集落刺激因子调节T淋巴细胞免疫功能的实验研究[J].免疫学杂志,2005,21(2):126-128.
-
3谢桂岚,李志祥,李哲先.外周血干细胞采集时机及其相关因素的探讨[J].中华内科杂志,2005,44(6):450-451. 被引量:13
-
4王琳,史克珊,白志明,陈晓霞,王智明,刘春苗,罗贤生,吴琴,符容香,黄姿英,黄淑梅,黄海妹,黎丽琼,何丽莉,许振胜.异基因造血干细胞移植治疗白血病的临床研究[J].白血病.淋巴瘤,2005,14(4):224-227. 被引量:1
-
5朱尊民,张琳,张鲁芳,郭建民,张茵.异基因移植CD56^+ CD16^+量对移植物抗宿主病影响[J].医药论坛杂志,2005,26(20):36-37.
-
6黄一虹,何徐彭,徐开林,李德鹏,李宝林,嵇月红,孙海英,潘秀英.烷化剂为主的预处理方案在造血干细胞移植中近期和远期毒性(英文)[J].中国组织工程研究与临床康复,2007,11(7):1382-1385. 被引量:3
-
7叶书来,应美爱,陈家萍.CS-3000PLUS血细胞分离机采集37名供者外周血造血干细胞效果的分析[J].中国输血杂志,2008,21(2):124-126. 被引量:8
-
8王三斌,郭坤元,胡灯明,刘林,彭利晖,尹波.以SEAM预处理方案行自体外周血干细胞移植治疗非何杰金淋巴瘤[J].中国组织工程研究与临床康复,2008,12(25):4811-4814. 被引量:4
-
9李敬东,韩效林,李志英.异基因骨髓联合外周干细胞移植术治疗白血病12例[J].医学信息(手术学分册),2008,21(7):622-624.
-
10王峰蓉,许兰平,刘代红,陈欢,张晓辉,赵婷,张圆圆,刘开彦,黄晓军.高危造血干细胞移植患者应用氟达拉滨替代环磷酰胺行预处理12例[J].中华器官移植杂志,2010(1):32-36. 被引量:2
-
1赵利东,王莹,刘惠杰,蔡志梅,杨建峰,朱学涛,刘波.异基因造血干细胞移植治疗恶性血液病[J].白血病.淋巴瘤,2007,16(1):60-61. 被引量:1
-
2党惠兵.自体外周血干细胞移植和自体骨髓移植的疗效对比分析[J].中国医疗前沿,2013,8(19):53-53.
-
3耿传营,陈文明.造血干细胞移植治疗多发性骨髓瘤的研究进展[J].白血病.淋巴瘤,2012,21(8):500-503.
-
4许兰平,黄晓军.造血干细胞移植后急性移植物抗宿主病的防治[J].中华血液学杂志,2009,30(8):574-576. 被引量:5
-
5邬海苏,张晓红.老年血液肿瘤的自体造血干细胞移植治疗[J].国外医学(输血及血液学分册),2005,28(3):257-259.
-
6左全和.乳腺癌大剂量化疗研究进展[J].中国医药指南,2012,10(8):54-55. 被引量:1
-
7陈运贤,钟雪云.白血病干细胞的靶向治疗[J].中华肿瘤杂志,2006,28(6):401-403. 被引量:6
-
8杨力勇,杨振岭.联合移植治恶性血液病有优势[J].中国社区医师(医学专业),2007,0(5):68-68.
-
9周红升,孟凡义.造血干细胞移植治疗恶性淋巴瘤[J].实用医院临床杂志,2007,4(6):16-20.
-
10郭智,何学鹏,陈惠仁,杨凯,陈鹏,王丙然,张媛,刘晓东.自体造血干细胞移植后白细胞介素-2免疫治疗对急性白血病长期生存的影响[J].中华临床医师杂志(电子版),2011,5(1):56-59. 被引量:3